(Q26825478)

BMC Health Services Research

language of work or name

1 reference

20 October 2014

2 references

27 October 2022

2 references

27 October 2022

14

1 reference

page(s)

469

1 reference

Creative Commons Attribution

copyright license

1 reference

27 October 2022

https://scigraph.springernature.com/pub.10.1186/1472-6963-14-469

0 references

cites work

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

How quickly do physicians adopt new drugs? The case of second-generation antipsychotics

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Variation in patient-sharing networks of physicians across the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

International variability in the reimbursement of cancer drugs by publically funded drug programs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Adoption of new drugs by physicians: a survival analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Colleague interactions and new drug prescribing behavior: the case of the initial prescription of antidepressants in Taiwanese medical centers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Mapping physician networks with self-reported and administrative data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Primary care physicians' adoption of new drugs is not associated with their clinical interests: a pharmacoepidemiologic study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

In with the new: the determinants of prescribing innovation by general practitioners in Ireland

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

The determinants of the adoption of pharmaceutical innovation: evidence from Taiwan

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Identifying early prescribers of cycloxygenase-2 inhibitors (COX-2s) in Nova Scotia, Canada: Considerations for targeted academic detailing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Primary care physicians' links to other physicians through Medicare patients: the scope of care coordination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Is new drug prescribing in primary care specialist induced?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing--a multilevel analysis of rosuvastatin prescription in south Sweden

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Factors affecting the uptake of new medicines in secondary care - a literature review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

New medicines in primary care: a review of influences on general practitioner prescribing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Benefits and harms of direct to consumer advertising: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Adoption of celecoxib and rofecoxib: a nationwide database study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

New drug uptake: qualitative comparison of high and low prescribing GPs’ attitudes and approach

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Disseminating innovations in health care

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Impact of pharmaceutical sales representatives on physician antibiotic prescribing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

The economic implications of therapeutic conservatism.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Patterns of preference for information sources in the adoption of new drugs by specialists

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Promotion of prescription drugs to consumers.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

The adoption of new drugs by doctors practising in group and solo practice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Physician and practice characteristics associated with the early utilization of new prescription drugs.

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Access to new medications to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Does the early adopter of drugs exist? A population-based study of general practitioners' prescribing of new drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Do clinical grant payment practices in phase 3 clinical trials influence subsequent clinical investigator prescribing behavior?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Diffusion of new drugs in Danish general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Diffusion of innovations: treatment of Alzheimer's disease in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Social Contagion and Innovation: Cohesion versus Structural Equivalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

The ‘Wise List’- A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-14-469

Innovation in high risk drug therapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4283087

Influences on GPs' decision to prescribe new drugs-the importance of who says what

28 November 2018

1 reference

12 December 2020

Recall accuracy for prescription medications: self-report compared with database information

1 reference

12 December 2020

[Adoption of new medications by prescribing physicians. The innovator physician]

1 reference

12 December 2020

Gender differences in practice style: a Dutch study of general practitioners

1 reference

12 December 2020

Scientific versus commercial sources of influence on the prescribing behavior of physicians

1 reference

12 December 2020

Changing patient management: what influences the practicing pediatrician?

1 reference

12 December 2020

Characterizing early prescribers of newly marketed drugs in Canada: a population-based study

1 reference

12 December 2020

The role of commercial sources in the adoption of a new drug

1 reference

12 December 2020

Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease

1 reference

12 December 2020

Influences on the prescribing of new drugs

1 reference

12 December 2020

Determinants for the adoption of angiotensin II receptor blockers by general practitioners

1 reference

12 December 2020

Prescriber profile and post-marketing surveillance

1 reference

12 December 2020

New drug prescribing by hospital doctors: the nature and meaning of knowledge

1 reference

12 December 2020

Regulating pharmaceutical markets: improving efficiency and controlling costs in the UK

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6963-14-469

1 reference